Key facts
- It has raised $28.2M; the latest was Later Stage VC ($14.2M) in Dec 2025.
- Notable investors include CDH Investments, Zhengxuan Investment, Optics Valley Industry Investment, CDBI Partners, Aqua Ventures (China) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Green-Agr Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Green-Agr Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Green-Agr Biotechnology
Operator and developer of an agricultural high-tech enterprise intended to offer antibiotic substitutes for animals. The company offers research and development, production, promotion, and application of antibiotic substitutes for animals, mainly involving probiotics, bacteriophages, plant extracts, new acid preparations and disinfectants, thereby enabling animals to improve recovery efficiency.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2019
- Website
- whgrnsw.com/
- Ownership
- Privately Held (backing)
Green-Agr Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Green-Agr Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Green-Agr Biotechnology in its N-PORT filings yet. We sweep new filings monthly.